What is the Diabetes Devices Market?

The Diabetes Devices Market refers to the industry that produces and sells devices and equipment designed to help manage and monitor diabetes. This includes glucose meters, insulin pumps, continuous glucose monitoring systems, and related products.

How big is the Diabetes Devices Market?

The global Diabetes Devices Market size was estimated at USD 14 billion in 2022 and is expected to reach USD 68.2 billion in 2032.

What is the Diabetes Devices Market growth?

The global Diabetes Devices Market is expected to grow at a compound annual growth rate of 11.3%. From 2023 To 2032

Who are the key companies/players in the Diabetes Devices Market?

Some of the key players in the Diabetes Devices Markets are F. Hoffmann-La-Roche Ltd, B. Braun Melsungen AG, Medtronic plc, Abbott, Sanofi SA, Tandem Diabetes Care, Inc., Becton Dickinson & Company, Terumo Corporation, Other Key Players

What is the current size of the Diabetes Devices Market?

The size of the Diabetes Devices Market varies and can change over time. As of my last knowledge update in September 2021, it was a multi-billion-dollar industry. For the most recent figures, please consult the latest market reports.

What are the key drivers of growth in the Diabetes Devices Market?

Key drivers of growth in the Diabetes Devices Market include the increasing prevalence of diabetes, advancements in technology, rising awareness about diabetes management, and the demand for more convenient and efficient devices.

Global Diabetes Devices Market By Product (Blood Glucose Monitoring devices and Insulin Delivery Devices), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 101839
Number of Pages: 279
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- F. Hoffmann-La-Roche Ltd
- B. Braun Melsungen AG
- Medtronic plc
- Abbott
- Sanofi SA
- Tandem Diabetes Care, Inc.
- Becton Dickinson & Company
- Terumo Corporation
- Other Key Players